Shots:
- FUJIFILM Diosynth Biotechnologies & Regeneron have entered into a 10-year manufacturing supply agreement, under which FUJIFILM will provide US-based manufacturing services for Regeneron
- As per the deal, FUJIFILM will receive ~$3B to manufacture biopharmaceuticals for Regeneron at its Holly Springs, North Carolina facility, which will begin operations in late 2025
- Holly Springs site is part of FUJIFILM’s global kojoX interconnected manufacturing network which offers standardized equipment, processes, & procedures across all sites to allow supply chain security & seamless tech transfers, with FUJIFILM bringing additional capacity online in 2025 & beyond
Ref: FUJIFILM Diosynth | Image: FUJIFILM Diosynth Biotechnologies & Regeneron
Related News:- Regeneron and Sanofi Report the US FDA’s Approval of Dupixent for Chronic Spontaneous Urticaria
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
